Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular outcomes in individuals with ovarian cancer: A retrospective cohort study.

Gynecologic oncology·2026
Same authorSame journal

An Abnormal Clone with a der(12;22)(q10;q10) as a Rare Abnormality Within the Context of dup(1)(q25q43), Deletion of ABL1 and a t(8;21) in a Pediatric Male Patient with Acute Myeloid Leukemia.

Journal of the Association of Genetic Technologists·2026
Same author

A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Complex Chromothripsis-like Features in Plasma Cell Myeloma: A Case Report and Review of the Literature.

Diagnostics (Basel, Switzerland)·2026
Same author

A Rare Case of De Novo Acute Myeloid Leukemia, Featuring a <i>KMT2A</i> (<i>MLL</i>) Amplification.

Diagnostics (Basel, Switzerland)·2026
Same author

#infertility education on Instagram: A Reliability Analysis in Brazil Using the DISCERN Instrument.

JBRA assisted reproduction·2026
Same journal

Laboratory Stewardship Rescues Misordered Familial Targeted Cytogenetic Testing Following Proband Genomic Testing: Case Series Review.

Journal of the Association of Genetic Technologists·2026
Same journal

Chronic Myelomonocytic Leukemia (CMML) with Novel t(1;3)(p36.2;p12): Dual-locus Genomic Disruption Associated with Early Mortality.

Journal of the Association of Genetic Technologists·2026
Same journal

Integrated Cytogenetic and FISH Profiling Reveals inv(16) Dominance and Cryptic 11q23 Lesions in AML and ALL: Clinical Significance from a Referral Cohort.

Journal of the Association of Genetic Technologists·2026
Same journal

The Many Classifications of Acute Myeloid Leukemia with Dysplasia: WHO vs ICC.

Journal of the Association of Genetic Technologists·2026
Same journal

Coexistence of Dual Chromosomal Abnormalities t(3;7) and t(9;22) in Case of B-Acute Lymphoblastic Leukemia: a Rare Genomic Profile with Diagnostic and Prognostic Challenges.

Journal of the Association of Genetic Technologists·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2025

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.4K

Bladder Cancer, a Cytogenomic Update.

Andrew Ruggero1, Mitchell Clark2, Alexandria Lewkowski1

  • 1The International Circle of Genetics Studies, Stony Brook Chapter, Stony Brook, NY.

Journal of the Association of Genetic Technologists
|September 2, 2024
PubMed
Summary
This summary is machine-generated.

Bladder cancer, a common malignancy, requires precise diagnosis and surveillance. Understanding key genetic mutations and utilizing advanced tools like UroVysion FISH aids in developing targeted therapies and improving patient outcomes.

More Related Videos

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

4.6K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.2K

Related Experiment Videos

Last Updated: Jun 14, 2025

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.4K
Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

4.6K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.2K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Bladder cancer is a prevalent and heterogeneous malignancy affecting 600,000 individuals annually.
  • High recurrence rates (66% within five years) underscore the need for accurate diagnosis and intensive surveillance.
  • Understanding the genetic-molecular landscape is crucial for effective bladder cancer management.

Purpose of the Study:

  • To consolidate the genetic-molecular understanding of bladder cancer.
  • To investigate key genetic players, including the 9p21 locus and specific genes (FGFR3, RB1, HRAS, TP53, TSC1, TERT, HER2, PIK3CA).
  • To highlight advancements in diagnostic and therapeutic strategies.

Main Methods:

  • Review and consolidation of current genetic-molecular data in bladder cancer.
  • Investigation of the 9p21 locus and associated genes.
  • Analysis of non-invasive cytogenetic diagnostic tools, such as UroVysion FISH.
  • Exploration of novel gene and immunotherapy approaches.

Main Results:

  • Identified key genetic drivers in bladder cancer, including the 9p21 locus and genes like FGFR3, RB1, HRAS, TP53, TSC1, TERT, HER2, and PIK3CA.
  • Highlighted the role of non-invasive tools like UroVysion FISH in analyzing these genetic alterations.
  • Indicated promising therapeutic avenues including gene therapy (interferon α2b, HER2, FGFR3) and immunotherapy.

Conclusions:

  • Accurate diagnosis and intensive surveillance are critical for managing bladder cancer due to its high heterogeneity and recurrence rate.
  • Understanding the genetic-molecular basis, particularly the 9p21 locus and specific genes, is fundamental for advancing bladder cancer treatment.
  • Novel diagnostic tools and targeted therapies, including gene and immunotherapy, offer promising strategies for improved patient outcomes.